Last edition
News about "Rupitasertib"
Evexta Bio, Roche Partner to Evaluate Novel Breast Cancer Combination Therapy
Evexta Bio has entered a clinical collaboration with Roche to evaluate its investigational therapy rupitasertib in combination with giredestrant for the treatment of advanced ER+, HER2-, ESR1-mutated breast cancer.
Rupitasertib | 05/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members